257 related articles for article (PubMed ID: 7796923)
1. [The changes in natriuretic peptide receptors (NP-R) in the lung and kidney in DOCA-salt hypertensive rats].
Liu LM; Yoshimi T
Nihon Naibunpi Gakkai Zasshi; 1995 May; 71(4):587-96. PubMed ID: 7796923
[TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic peptide receptors in renal papilla of DOCA-salt hypertensive rats.
Nuglozeh E; Gauquelin G; Garcia R; Tremblay J; Schiffrin EL
Am J Physiol; 1990 Jul; 259(1 Pt 2):F130-7. PubMed ID: 2165357
[TBL] [Abstract][Full Text] [Related]
3. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
[TBL] [Abstract][Full Text] [Related]
4. Decreased density of vascular receptors for atrial natriuretic peptide in DOCA-salt hypertensive rats.
Schiffrin EL; St-Louis J
Hypertension; 1987 May; 9(5):504-12. PubMed ID: 3032791
[TBL] [Abstract][Full Text] [Related]
5. Increased plasma brain natriuretic peptide levels in DOCA-salt hypertensive rats: relation to blood pressure and cardiac concentration.
Yokota N; Aburaya M; Yamamoto Y; Kato J; Kitamura K; Kida O; Eto T; Minamino N; Kangawa K; Matsuo H
Biochem Biophys Res Commun; 1990 Dec; 173(2):632-8. PubMed ID: 2148083
[TBL] [Abstract][Full Text] [Related]
6. Increased renal atrial natriuretic peptide synthesis in rats with deoxycorticosterone acetate-salt treatment.
Lee YJ; Shin SJ; Tan MS; Hsieh TJ; Tsai JH
Am J Physiol; 1996 Oct; 271(4 Pt 2):F779-89. PubMed ID: 8898007
[TBL] [Abstract][Full Text] [Related]
7. Computerized approach using autoradiography to quantify atrial natriuretic peptide receptors in the DOCA-salt hypertensive rat kidney.
Takatori K; Ogura T; Ota Z
Regul Pept; 1991 Aug; 35(2):115-25. PubMed ID: 1661902
[TBL] [Abstract][Full Text] [Related]
8. Gene expression of natriuretic peptide receptors in rats with DOCA-salt hypertension.
Nuglozeh E; Mbikay M; Stewart DJ; Legault L
Am J Physiol; 1997 Oct; 273(4):C1427-34. PubMed ID: 9357789
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiological role of augmented atrial natriuretic polypeptide gene expression in DOCA-salt hypertension. Effects of atrial natriuretic polypeptide monoclonal antibody.
Itoh H; Nakao K; Mukoyama M; Arai H; Yamada T; Saito Y; Shiono S; Hosoda K; Shirakami G; Suga S
Am J Hypertens; 1991 Jan; 4(1 Pt 1):39-44. PubMed ID: 1706603
[TBL] [Abstract][Full Text] [Related]
10. Renal atrial natriuretic peptide receptors binding properties and function are resistant to DOCA-salt-induced hypertension in rats.
Li X; Woodard GE; Brown J; Rosado JA
Regul Pept; 2006 Dec; 137(3):114-20. PubMed ID: 16904201
[TBL] [Abstract][Full Text] [Related]
11. Accelerated secretion of brain natriuretic peptide from the hypertrophied ventricles in experimental malignant hypertension.
Kohno M; Horio T; Yoshiyama M; Takeda T
Hypertension; 1992 Feb; 19(2):206-11. PubMed ID: 1531333
[TBL] [Abstract][Full Text] [Related]
12. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.
Itoh H; Nakao K; Mukoyama M; Yamada T; Hosoda K; Shirakami G; Morii N; Sugawara A; Saito Y; Shiono S
J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors.
Hirata Y; Suzuki Y; Suzuki E; Hayakawa H; Kimura K; Goto A; Omata M; Minamino N; Kangawa K; Matsuo H
J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160
[TBL] [Abstract][Full Text] [Related]
14. C-atrial natriuretic peptide (ANP)
Lu YY; Li SJ; Zhang Z; He S; Guo YT; Hong MN; Shao S; Wang RQ; Zhang J; Wang JG; Gao PJ; Li XD
Exp Cell Res; 2023 Oct; 431(1):113738. PubMed ID: 37572787
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II and atrial natriuretic factor-binding sites in various tissues in hypertension: comparative receptor localization and changes in different hypertension models in the rat.
Wilson SK; Lynch DR; Ladenson PW
Endocrinology; 1989 Jun; 124(6):2799-808. PubMed ID: 2542000
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of adrenal cortical and medullary atrial natriuretic peptide and gene expression in rats with deoxycorticosterone acetate-salt treatment.
Lai FJ; Shin SJ; Lee YJ; Lin SR; Jou WY; Tsai JH
Endocrinology; 2000 Jan; 141(1):325-32. PubMed ID: 10614654
[TBL] [Abstract][Full Text] [Related]
17. Phasic plasma atrial natriuretic polypeptide changes in DOCA-salt hypertensive rats.
Sato Y; Ito Y; Ando K; Ogata E; Fujita T
Jpn Heart J; 1990 Sep; 31(5):703-11. PubMed ID: 2148777
[TBL] [Abstract][Full Text] [Related]
18. Defective ANF-R2/ANP-C receptor-mediated signalling in hypertension.
Marcil J; Anand-Srivastava MB
Mol Cell Biochem; 1995; 149-150():223-31. PubMed ID: 8569733
[TBL] [Abstract][Full Text] [Related]
19. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
[TBL] [Abstract][Full Text] [Related]
20. Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension.
Ndisang JF; Jadhav A
J Pharmacol Exp Ther; 2010 Jul; 334(1):87-98. PubMed ID: 20392817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
